The development of new radionuclide generator systems for nuclear medicine applications
Abstract
Radioisotope generator systems have traditionally played a central role in nuclear medicine in providing radioisotopes for both research and clinical applications. In this paper, the development of several tungsten-188/rhenium-188 prototype generators which provide rhenium-188 for radioimmunotherapy (RAIT) is discussed. The authors have recently demonstrated that carrier-free iridium-194 can be obtained from the activated carbon system from decay of reactor-produced osmium-194 for potential RAIT applications. Instrumentation advances such as the new generation of high-count-rate (fast) gamma camera systems for first-pass technology require the availability of generator-produced ultra short-lived radioisotopes for radionuclide angiography (RNA). The activated carbon generator is an efficient system to obtain ultra short-lived iridium-191 m from osmium-191 for RNA. In addition, the growing number of PET centers has stimulated research in generators which provide positron-emitting radioisotopes. Copper-62, obtained from the zinc-62 generator, is currently used for PET evaluation of organ perfusion. The availability of the parent radioisotopes, the fabrication and use of these generators, and the practical factors for use of these systems in the radiopharmacy are discussed.
- Publication:
-
Presented at the 4th European Symposium on Radiopharmacy and Radiopharmaceuticals
- Pub Date:
- 1991
- Bibcode:
- 1991rara.symp....1K
- Keywords:
-
- Activated Carbon;
- Computer Aided Tomography;
- Immunology;
- Nuclear Medicine;
- Radiation Therapy;
- Radioactive Isotopes;
- Angiography;
- Copper Isotopes;
- Iridium Isotopes;
- Osmium Isotopes;
- Rhenium Isotopes;
- Ribonucleic Acids;
- Tungsten Isotopes;
- Zinc Isotopes;
- Nuclear and High-Energy Physics